CCL27 and infection: Mucosal delivery methods, such as intranasal or oral administration, enhance DC–ILC communication at barrier sites, where specific ILC subsets, including ILC1s in the lungs, ILC2s in mucosal tissues, and ILC3s in the gut, are strategically positioned to rapidly respond to infection.